1. Home
  2. NNNN vs NYAX Comparison

NNNN vs NYAX Comparison

Compare NNNN & NYAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

HOLD

Current Price

$25.65

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo Nayax Ltd.

NYAX

Nayax Ltd.

HOLD

Current Price

$54.01

Market Cap

1.6B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
NNNN
NYAX
Founded
2021
2005
Country
Germany
Israel
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.6B
IPO Year
2025
N/A

Fundamental Metrics

Financial Performance
Metric
NNNN
NYAX
Price
$25.65
$54.01
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$47.50
AVG Volume (30 Days)
73.0K
10.2K
Earning Date
04-28-2026
03-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.06
0.63
Revenue
$6,920,153.00
$369,938,000.00
Revenue This Year
N/A
$29.95
Revenue Next Year
N/A
$23.27
P/E Ratio
$410.25
$86.04
Revenue Growth
N/A
26.84
52 Week Low
$5.18
$32.38
52 Week High
$55.65
$60.77

Technical Indicators

Market Signals
Indicator
NNNN
NYAX
Relative Strength Index (RSI) 44.80 47.32
Support Level $22.10 $51.24
Resistance Level $34.00 $56.76
Average True Range (ATR) 6.84 1.21
MACD -0.40 -0.90
Stochastic Oscillator 22.21 32.13

Price Performance

Historical Comparison
NNNN
NYAX

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

About NYAX Nayax Ltd.

Nayax Ltd is an end-to-end retail technology platform for unattended commerce. It provides consumers with digital, cashless payments, and connected commerce experiences, enhancing consumer conversion and loyalty. Its platform addresses the entire unattended commerce value chain, including a payments infrastructure, a commerce software suite, a consumer engagement platform, and integrated POS devices. The company addresses a broad range of retail verticals, including all types of vending machines, coffee machines, unattended checkout counters, self-service kiosks, ticketing machines, car wash stations, gaming machines, amusement rides, laundromats, EV charging stations, and many more.

Share on Social Networks: